Delivery Order SPE2DE24DA010-SPE2D625F3QH5

Award Date 6/24/25
Potential Completion Date 6/27/25
Potential Value $9.5K
Federal Agency
Medical Supply Chain
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Santa Clara, CA 95054, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $33,700.00, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Abbott Laboratories Inc. through its Abbott Vascular Inc. division. The contract is a fixed-price delivery order for the delivery of cardiovascular medical devices, including stents, pacemakers, heart valves, implantable cardiac monitors, mapping systems, and specialized surgical implants. The contract has an ultimate completion date of April 15, 2025....
This federal contract award, valued at $11,750.00, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Abbott Laboratories Inc., a global healthcare company, through its Abbott Vascular Inc. division. The contract is a fixed-price delivery order with economic price adjustment, with a completion date of March 3, 2025. The award does not have a set-aside designation, indicating full and open competition. The contract provides for the delivery of...
This federal contract award, valued at $1,262.00, was issued by the Defense Logistics Agency (DLA) to Abbott Laboratories Inc., a multinational pharmaceutical and medical device manufacturer, for the delivery of cardiovascular medical devices and related services. The contract is a fixed-price delivery order with economic price adjustment, with a period of performance ending on March 27, 2025. Abbott Laboratories Inc., through its Abbott Vascular Inc. division, is a key supplier of advanced...
This contract award by the Defense Logistics Agency (DLA) to Abbott Laboratories Inc. is for the delivery of cardiovascular medical devices, including stents, pacemakers, heart valves, implantable cardiac monitors, mapping systems, and specialized surgical implants. The $9,500.00 fixed-price delivery order has an ultimate completion date of May 30, 2024. Abbott Laboratories Inc., through its Abbott Vascular Inc. division, is a major supplier of advanced medical technologies to federal healthcare...
This federal contract award, valued at $24,350.00, was issued by the Defense Logistics Agency (DLA) to Abbott Laboratories Inc. through its Abbott Vascular Inc. division. The contract is a firm fixed-price delivery order with economic price adjustment, with an ultimate completion date of June 18, 2024. The award provides for the delivery of cardiovascular medical devices, including stents, pacemakers, heart valves, implantable cardiac monitors, mapping systems, and specialized surgical implants....
This is a federal contract award from the Defense Logistics Agency (DLA) to Abbott Laboratories Inc. through its Abbott Vascular Inc. division. The $44,742.80 fixed-price delivery order is for the provision of cardiovascular medical devices, including stents, pacemakers, heart valves, implantable cardiac monitors, mapping systems, and surgical implants. The ultimate completion date for this contract is October 25, 2024. This contract award is part of a larger Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $14,850.00, was issued by the Defense Logistics Agency (DLA) to Abbott Laboratories Inc. through its Abbott Vascular Inc. division. The contract is a delivery order without any set-aside designations, indicating full and open competition. The contract covers the delivery of a range of cardiovascular medical devices, including stents, pacemakers, heart valves, implantable cardiac monitors, mapping systems, and specialized surgical implants. These products...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Abbott Laboratories Inc. through its Abbott Vascular Inc. division. The $2,800.00 fixed-price with economic price adjustment delivery order is for the provision of cardiovascular medical devices, including stents, pacemakers, heart valves, implantable cardiac monitors, mapping systems, and specialized surgical implants. The contract has an ultimate completion date of June 17, 2024. This award is part of a larger...
This federal contract award, valued at $10,124, was issued by the Defense Logistics Agency (DLA) to Abbott Laboratories Inc. and its Abbott Vascular Inc. division. The contract is a Delivery Order for the provision of advanced cardiovascular medical devices, including stents, pacemakers, heart valves, implantable cardiac monitors, mapping systems, and specialized surgical implants. The contract has a fixed-price with economic price adjustment pricing type and an ultimate completion date of...
This federal contract award, valued at $24,350.00, was issued by the Defense Logistics Agency (DLA) to Abbott Laboratories Inc., a global healthcare company that specializes in medical devices, diagnostics, and pharmaceuticals. The award is a delivery order contract with a fixed price and economic price adjustment mechanism. The contract has no set-aside designation, indicating full and open competition. The contract requires Abbott Laboratories Inc., through its Abbott Vascular Inc. division,...
  • SPE2DE24DA010
    Indefinite Delivery Contract
  • SPE2DE24DA010-SPE2D625F3QH5
    Delivery Order

This is a fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Abbott Laboratories Inc., a global healthcare company, for the delivery of cardiovascular medical devices and related services. The contract has a ceiling value of $9,500.00 and a period of performance ending on June 27, 2025. The award was made without a set-aside designation, indicating full and open competition.

Abbott Laboratories Inc., through its Abbott Vascular Inc. division, is a critical supplier of advanced cardiovascular medical technologies to federal government agencies, particularly the Department of Veterans Affairs (VA) and the DLA. The company provides a comprehensive range of products, including stents, pacemakers, heart valves, implantable cardiac monitors, mapping systems, and specialized surgical implants, which support complex medical procedures and improve patient outcomes across federal healthcare systems.

The contract award is part of Abbott Laboratories Inc.'s larger federal contracting portfolio, which includes several significant Indefinite Delivery Contracts (IDCs) and Blanket Purchase Agreements (BPAs) with the DLA and VA for cardiovascular medical devices, diagnostic equipment, and related services. These contracts demonstrate the company's strategic importance in federal healthcare procurement and its ability to deliver both small-scale and large-scale medical technology solutions to support the medical needs of federal healthcare systems.

Generated 9/28/25, 2:06 AM